Many popular peptides can not be compounded by pharmacies for human use as a result of latest FDA regulatory changes. The FDA has moved a lot of of such substances to Category two of its Bulk Drug Substances listing, citing basic safety risks or inadequate facts, creating them ineligible for compounding.The peptides we pointed out above are… Read More